Multiple Sclerosis, An Issue of Neurologic Clinics: The Clinics: Internal Medicine, cartea 42-1
Editat de Carrie M. Hershen Limba Engleză Hardback – 22 noi 2023
Din seria The Clinics: Internal Medicine
- 5%
Preț: 394.41 lei - 15%
Preț: 503.11 lei - 5%
Preț: 608.74 lei - 5%
Preț: 466.20 lei - 5%
Preț: 633.40 lei - 5%
Preț: 574.16 lei - 5%
Preț: 599.73 lei - 5%
Preț: 600.12 lei - 5%
Preț: 599.98 lei - 5%
Preț: 600.03 lei - 5%
Preț: 600.34 lei - 5%
Preț: 599.27 lei - 5%
Preț: 616.99 lei - 5%
Preț: 464.77 lei - 5%
Preț: 465.73 lei - 5%
Preț: 466.02 lei - 5%
Preț: 536.41 lei - 5%
Preț: 535.73 lei - 5%
Preț: 466.46 lei - 5%
Preț: 532.76 lei - 5%
Preț: 468.73 lei - 5%
Preț: 465.73 lei - 5%
Preț: 449.04 lei - 5%
Preț: 451.15 lei - 5%
Preț: 575.59 lei - 5%
Preț: 534.89 lei - 5%
Preț: 551.34 lei - 5%
Preț: 582.64 lei - 5%
Preț: 515.34 lei - 5%
Preț: 465.10 lei - 5%
Preț: 600.54 lei - 5%
Preț: 599.72 lei - 5%
Preț: 590.42 lei - 5%
Preț: 481.95 lei - 25%
Preț: 463.36 lei - 5%
Preț: 634.80 lei - 25%
Preț: 461.96 lei - 5%
Preț: 666.99 lei - 5%
Preț: 666.70 lei - 5%
Preț: 633.37 lei - 5%
Preț: 637.44 lei - 5%
Preț: 666.81 lei - 5%
Preț: 670.00 lei - 5%
Preț: 337.63 lei - 5%
Preț: 793.48 lei - 5%
Preț: 667.38 lei - 5%
Preț: 666.84 lei - 5%
Preț: 655.22 lei - 5%
Preț: 633.37 lei - 5%
Preț: 633.59 lei
Preț: 665.83 lei
Preț vechi: 700.88 lei
-5% Nou
Puncte Express: 999
Preț estimativ în valută:
117.82€ • 137.40$ • 103.45£
117.82€ • 137.40$ • 103.45£
Carte disponibilă
Livrare economică 26 decembrie 25 - 09 ianuarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323939171
ISBN-10: 0323939171
Pagini: 240
Dimensiuni: 152 x 229 x 143 mm
Greutate: 0.7 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323939171
Pagini: 240
Dimensiuni: 152 x 229 x 143 mm
Greutate: 0.7 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Multiple Sclerosis Diagnostic Delay and Misdiagnosis
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Bruton's Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?
Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Women's Health and Pregnancy in Multiple Sclerosis
Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Era of COVID-19 in Multiple Sclerosis Care
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Bruton's Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?
Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Women's Health and Pregnancy in Multiple Sclerosis
Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Era of COVID-19 in Multiple Sclerosis Care